Key facts
- Cupron’s last known valuation is $45.4M (Feb 2025).
- It has raised $10.2M across 1 recorded rounds; the latest was Seed Round ($1.8M) in Sep 2019.
- Notable investors include Gates Foundation.
- Cupron has filed 1 Form D with the SEC, most recently Nov 2019 ($1.8M sold to 24 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cupron
Funding rounds
1 roundsAbout Cupron
Developer of a copper-based antimicrobial technology designed to enhance product protection and sustainability. The company offers proprietary formulations with metal ion antimicrobial technology that harnesses the properties of copper for healthcare, consumer, industrial, and military applications, enabling industries like personal care and water purification to achieve better performance and cost-effective antimicrobial systems.
- Sector
- Materials and Resources
- HQ
- Richmond, VA, United States
- Founded
- 2000
- Employees
- 14
- Website
- cupron.com/
- Ownership
- Privately Held (backing)
Cupron doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cupron shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cupron in its N-PORT filings yet. We sweep new filings monthly.